Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-28 @ 11:53 PM
Study NCT ID:
NCT06030934
Status:
UNKNOWN
Last Update Posted:
2023-09-11
First Post:
2023-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-03
First Submit QC Date:
None
Study First Post Date:
2023-09-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-03
Last Update Post Date:
2023-09-11
Last Update Post Date Type:
ACTUAL